Overview

Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty

Status:
Recruiting
Trial end date:
2023-04-30
Target enrollment:
0
Participant gender:
All
Summary
The investigators are evaluating the postoperative outcomes in patients undergoing total knee arthroplasty that receive either systemic lidocaine or ultrasound-guided adductor canal block as part of their anesthetic plan.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Rhode Island Hospital
Treatments:
Lidocaine
Criteria
Inclusion Criteria:

- ASA PS 1-3 patients undergoing primary, unilateral total knee arthroplasty

Exclusion Criteria:

- ASA PS classification of 4 or greater

- Pre-existing neuropathy

- Coagulopathy

- Chronic opioid consumption (>3 months)

- Infection at the site

- Known allergy to study medications (lidocaine)

- High grade atrioventricular block (cardiac conduction system impairment)

- A history of CVA/TIA

- Currently using lidocaine patches

- Known liver disease